Results 291 to 300 of about 310,541 (331)
Lysophosphatidic acid-induced Arf6-driven macropinocytosis of CD147<sup>+</sup> extracellular vesicles promotes sorafenib resistance of hepatocellular carcinoma. [PDF]
Int J Biol SciQian L +13 more
europepmc +1 more source
N6-Methyladenosine Modification of circIST1 Promotes Hypoxia-Inducible Factor α-mediated Glycolysis and Progression in Hepatocellular Carcinoma. [PDF]
MedComm (2020)Zhan Y +12 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Proceedings of the 33rd international ACM SIGIR conference on Research and development in information retrieval, 2010
In this poster, we develop a novel method, called HCC, for hierarchical co-clustering. HCC brings together two interrelated but distinct themes from clustering: hierarchical clustering and co-clustering. The goal of the former theme is to organize clusters into a hierarchy that facilitates browsing and navigation, while the goal of the latter theme is ...
Jingxuan Li, Tao Li
openaire +1 more source
In this poster, we develop a novel method, called HCC, for hierarchical co-clustering. HCC brings together two interrelated but distinct themes from clustering: hierarchical clustering and co-clustering. The goal of the former theme is to organize clusters into a hierarchy that facilitates browsing and navigation, while the goal of the latter theme is ...
Jingxuan Li, Tao Li
openaire +1 more source
2021
Nonalcoholic fatty liver disease (NAFLD) is one of the major drivers for the rising trend in hepatocellular carcinoma (HCC). Over the past three decades, the incidence of both NAFLD and HCC have increased two- to threefold. It has been forecasted that the number of patients with NAFLD in the Unites States will reach 101 million by 2030; global increase
Bubu A, Banini, Arun J, Sanyal
openaire +2 more sources
Nonalcoholic fatty liver disease (NAFLD) is one of the major drivers for the rising trend in hepatocellular carcinoma (HCC). Over the past three decades, the incidence of both NAFLD and HCC have increased two- to threefold. It has been forecasted that the number of patients with NAFLD in the Unites States will reach 101 million by 2030; global increase
Bubu A, Banini, Arun J, Sanyal
openaire +2 more sources
Der Radiologe, 2007
Hepatocellular carcinoma (HCC) is one of the most frequently diagnosed tumour diseases throughout the world. In the vast majority of cases those affected are high-risk patients with chronic viral hepatitis and/or liver cirrhosis, which means there is a clearly identifiable target group for HCC screening.
openaire +2 more sources
Hepatocellular carcinoma (HCC) is one of the most frequently diagnosed tumour diseases throughout the world. In the vast majority of cases those affected are high-risk patients with chronic viral hepatitis and/or liver cirrhosis, which means there is a clearly identifiable target group for HCC screening.
openaire +2 more sources
Journal of Hepatology, 2012
Hepatocellular carcinoma (HCC) is a highly prevalent and lethal neoplasia, the management of which has significantly improved during the last few years. A better knowledge of the natural history of the tumor and the development of staging systems that stratify patients according to the characteristics of the tumor, the liver disease, and the ...
Carlos Rodríguez, de Lope +4 more
openaire +2 more sources
Hepatocellular carcinoma (HCC) is a highly prevalent and lethal neoplasia, the management of which has significantly improved during the last few years. A better knowledge of the natural history of the tumor and the development of staging systems that stratify patients according to the characteristics of the tumor, the liver disease, and the ...
Carlos Rodríguez, de Lope +4 more
openaire +2 more sources
Reviews on Recent Clinical Trials, 2008
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide with increasing incidence in the Western World. In contrast to most other malignancies, only surgical and local ablative therapeutic options have shown efficacy in patients with HCC. Systemic chemotherapy has failed to show a substantial benefit for these patients.
Tim F, Greten +2 more
openaire +2 more sources
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide with increasing incidence in the Western World. In contrast to most other malignancies, only surgical and local ablative therapeutic options have shown efficacy in patients with HCC. Systemic chemotherapy has failed to show a substantial benefit for these patients.
Tim F, Greten +2 more
openaire +2 more sources
Abdominal Imaging, 2011
Imaging techniques play a crucial role in the management of patients with liver cirrhosis in whom a nodular hepatic lesion is detected. The most severe complication of patients with liver cirrhosis is the development of a hepatocellular carcinoma (HCC), and the prognosis of the disease depends on the tumoral stage.
Carmen, Ayuso +2 more
openaire +2 more sources
Imaging techniques play a crucial role in the management of patients with liver cirrhosis in whom a nodular hepatic lesion is detected. The most severe complication of patients with liver cirrhosis is the development of a hepatocellular carcinoma (HCC), and the prognosis of the disease depends on the tumoral stage.
Carmen, Ayuso +2 more
openaire +2 more sources